Uma Karthika R, Srinivasa Rao R, Sahoo Suchismita, Shashikala P, Kanungo Reba, Jayachandran S, Prashanth K
Department of Biotechnology, School of Life Sciences, Pondicherry University, R. Venkataraman Nagar, Kalapet, Puducherry 605 014, India.
Department of Clinical Microbiology, Pondicherry Institute of Medical Sciences, Puducherry 605 014, India.
J Med Microbiol. 2009 Apr;58(Pt 4):430-435. doi: 10.1099/jmm.0.002105-0.
Nosocomial infections caused by Acinetobacter baumannii often prove difficult to treat owing to their multiple drug resistance. Carbapenems play a pivotal role in the management of severe Acinetobacter infections. However, reports of carbapenem resistance have been increasing alarmingly due to production of a variety of carbapenemases including metallo-beta-lactamases (MBLs). This study investigated by both phenotypic and genotypic assays the prevalence of MBLs in a total of 55 A. baumannii strains isolated from a South Indian tertiary care hospital. Random amplified polymorphic DNA (RAPD) genotyping and antimicrobial susceptibility testing for nine clinically relevant antibiotics was done for characterization of isolates. Phenotypic expression of MBLs was examined by a simple double disc synergy (DDS) test, and the presence of the most frequent MBL coding genes, bla(IMP1) and bla(VIM2), was checked by PCR. RAPD analysis generated six clusters of isolates and there was very little correlation between RAPD clusters and resistant profiles. Most of the isolates showed complete or high resistance to imipenem (100 %), meropenem (89 %), amikacin (80 %), cefotaxime (89 %) and ciprofloxacin (72 %). In addition, 44 % of isolates showed a high MIC level (> or =16 microg ml(-1)) for meropenem. Thirty-nine isolates (70.9 %) were positive for MBL production by the DDS test while bla(IMP1) gene amplification was seen only in 23 isolates (42 %). Interestingly, none of the isolates showed amplification of bla(VIM2). Further investigations on DDS-positive/PCR-negative isolates by spectrophotometric assay showed MBL activity in most of the isolates, suggesting involvement of other genes. The high incidence of isolates possessing MBL activity in the present study represents an emerging threat of complete resistance to carbapenems among Acinetobacter spp. in India.
鲍曼不动杆菌引起的医院感染由于其多重耐药性,往往难以治疗。碳青霉烯类药物在严重不动杆菌感染的治疗中起着关键作用。然而,由于包括金属β-内酰胺酶(MBLs)在内的多种碳青霉烯酶的产生,碳青霉烯耐药的报道一直在惊人地增加。本研究通过表型和基因型分析方法,对从印度南部一家三级护理医院分离出的总共55株鲍曼不动杆菌中MBLs的流行情况进行了调查。对分离株进行随机扩增多态性DNA(RAPD)基因分型和对九种临床相关抗生素的药敏试验,以进行分离株的鉴定。通过简单的双纸片协同(DDS)试验检测MBLs的表型表达,并通过PCR检测最常见的MBL编码基因bla(IMP1)和bla(VIM2)的存在情况。RAPD分析产生了六个分离株簇,RAPD簇与耐药谱之间几乎没有相关性。大多数分离株对亚胺培南(100%)、美罗培南(89%)、阿米卡星(80%)、头孢噻肟(89%)和环丙沙星(72%)表现出完全或高度耐药。此外,44%的分离株对美罗培南表现出高MIC水平(≥16μg/ml(-1))。39株分离株(70.9%)通过DDS试验检测MBL产生呈阳性,而bla(IMP1)基因扩增仅在23株分离株(42%)中可见。有趣的是,没有分离株显示bla(VIM2)扩增。通过分光光度法对DDS阳性/PCR阴性分离株的进一步研究表明,大多数分离株具有MBL活性,提示存在其他基因。本研究中具有MBL活性的分离株的高发生率代表了印度不动杆菌属对碳青霉烯类药物完全耐药的一种新出现的威胁。